HCV Prevention
Sexual Transmission of HCV Is Increasing Among Gay and Bi Men with HIV
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 16 September 2015 00:00
- Written by Liz Highleyman
Sexual transmission of hepatitis C virus (HCV) is occurring among HIV-positive men who have sex with men, associated with receptive anal sex and non-injection drug use, and a small subset of men may be prone to recurrent infection after being cured of hepatitis C, according to a meta-analysis reported in the August 7 online edition of AIDS.
IAS 2015: PrEP and the Risk of Hepatitis C Virus Infection [VIDEO]
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 12 August 2015 00:00
- Written by Gregory Fowler
Are gay and bisexual men who take Truvada for HIV pre-exposure prophylaxis (PrEP) at greater risk for sexually transmitted hepatitis C virus (HCV) infection? Experts discussed this issue and others at a media briefing on HIV and hepatitis coinfection at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last month in Vancouver.
Studies Shed Light on Hepatitis C Virus Sexual Transmission among Gay Men
- Details
- Category: HCV Sexual Transmission
- Published on Tuesday, 20 May 2014 00:00
- Written by Liz Highleyman
Hepatitis C virus (HCV) transmission among HIV positive gay men has leveled off in Amsterdam -- one of the first cities with an outbreak of apparently sexually transmitted HCV infection -- and it continues to be rare among HIV negative men who have sex with men, according to recent studies. Other research looked at HCV sexual transmission among HIV positive and negative men in Switzerland, and at the association between HCV viral load in blood and semen.
HIV-Negative Gay Men May Be Susceptible to Sexually Transmitted Hepatitis C
- Details
- Category: HCV Sexual Transmission
- Published on Thursday, 09 July 2015 00:00
- Written by Liz Highleyman
Several studies have shown that hepatitis C virus (HCV) can be sexually transmitted among HIV-positive men who have sex with men, but HIV-negative gay and bisexual men may be at risk as well if they share similar risk factors, according to a report in the June 2015 Journal of Viral Hepatitis.
EASL 2014: Researchers Look at Treatment as Prevention for Hepatitis C
- Details
- Category: HCV Treatment
- Published on Friday, 25 April 2014 00:00
- Written by Liz Highleyman
Widespread hepatitis C treatment with effective new direct-acting antivirals could dramatically reduce hepatitis C virus (HCV) transmission, but making this work on a large scale will require efforts to scale up HCV screening and bring down drug costs, according to several presentations at the EASL International Liver Congress this month in London.
EASL 2015: Hepatitis C Treatment Could Cut HCV Transmission Among UK Gay Men in Half
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 17 June 2015 00:00
- Written by Keith Alcorn, Aidsmap
Access to more effective hepatitis C treatment could reduce new infections among men who have sex with men in the United Kingdom by half over the next decade, according to a mathematical modeling study presented at the European Association for the Study of the Liver (EASL) International Liver Congress in Vienna in April.
EASL 2014: Treatment as Prevention for Drug Users Could Slash HCV Prevalence
- Details
- Category: Injection Drug Use
- Published on Sunday, 13 April 2014 00:00
- Written by Keith Alcorn
A combination of increased testing, improved linkage to care, and earlier treatment with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C among people who inject drugs in France over the next 10 years, as well as reducing the burden of disease arising from cirrhosis over 40 years, according to a study presented at the 49th EASL International Liver Congress (EASL 2014) last week in London.
EASL 2015: Reinfection after HCV Cure - Long-term Support Needed for People Who Have Injected Drugs
- Details
- Category: Injection Drug Use
- Published on Wednesday, 10 June 2015 00:00
- Written by Keith Alcorn, Aidsmap
Reinfection rates after a hepatitis C cure among people who inject drugs, as well as past drug users, are relatively low, according to findings from studies from Norway and Canada presented at the European Association for the Study of the Liver (EASL) 50th International Liver Congress in Vienna in April. The findings suggest that current and former injection drug users who have been cured of hepatitis C require ongoing support to remain free of HCV, but also indicate that fears of a high rate of reinfection should not be used as a reason to withhold hepatitis C treatment from people who inject drugs.
AASLD 2013: HCV Levels in Semen May Correspond to Blood Viral Load
- Details
- Category: HCV Prevention
- Published on Wednesday, 18 December 2013 00:00
- Written by Liz Highleyman
HIV positive men with higher hepatitis C virus (HCV) RNA levels in their blood during acute infection were more likely to have HCV in their semen as well, which may raise the risk of sexual transmission, researchers reported last month at the 64thAASLD Liver Meeting in Washington, DC.
EASL 2015: Civacir Immune Globulin May Help Prevent HCV Reinfection after Liver Transplant
- Details
- Category: HCV Prevention
- Published on Wednesday, 06 May 2015 00:00
- Written by Liz Highleyman
Civacir, a hepatitis C immune globulin or antibody product, reduced the likelihood of hepatitis C virus infecting the new liver graft after transplantation in patients who were receiving but had not yet completed antiviral treatment, according to preliminary study findings presented at the European Association for the Study of the Liver (EASL) 50th International Liver Congress last month in Vienna.
Hepatitis C Virus Can Live on Surfaces for Up to 6 Weeks
- Details
- Category: HCV Prevention
- Published on Thursday, 12 December 2013 00:00
- Written by Liz Highleyman
Hepatitis C virus (HCV) in dried droplets of blood or plasma can remain infectious on uncovered surfaces at temperatures of 4° or 22° C (39° or 72° F) for up to 6 weeks, resulting in potential for transmission in healthcare settings or during injection drug preparation, researchers reported in the November 23, 2013, advance edition of the Journal of Infectious Diseases.
CROI 2015: HCV Sexual Transmission Linked to Anal Sex, Drug Use, Lower CD4 Count
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 25 March 2015 00:00
- Written by Liz Highleyman
In addition to the usual risk factors for hepatitis C virus (HCV) sexual transmission seen in most previous studies -- such as anal sex and having other sexually transmitted infections -- researchers in the Netherlands also saw an association with nasal and injection drug use and lower CD4 T-cell count, they reported in a poster presentation at the recent 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle.
Injection Drug Users Who Know They Have Hepatitis C Practice "Sero-Sharing"
- Details
- Category: HCV Prevention
- Published on Wednesday, 04 December 2013 00:00
- Written by Liz Highleyman
People who inject drugs who know they are hepatitis C virus (HCV) positive are more likely to share syringes and injection equipment with others who are also infected, and less likely to do so with people who are HCV negative or unknown -- the equivalent of sexual "serosorting," according to a report in the December 15, 2013, Journal of Infectious Diseases.
Clinicians Report 2 Acute HCV Infections in Kaiser PrEP Program
- Details
- Category: HCV Sexual Transmission
- Published on Friday, 20 February 2015 00:00
- Written by Liz Highleyman
Two HIV negative men gay receiving HIV pre-exposure prophylaxis (PrEP) through Kaiser Permanente in San Francisco were newly infected with hepatitis C virus (HCV), with sex being their only apparent risk factor, Kaiser clinicians reported in the February 18 issue of Clinical Infectious Diseases.
ICAAC 2013: Is HCV Infection Increasing Among HIV+ Gay Men in Japan?
- Details
- Category: HCV Sexual Transmission
- Published on Sunday, 22 September 2013 00:00
- Written by Liz Highleyman
The incidence of acute hepatitis C virus (HCV) coinfection has increased in recent years at the largest HIV clinic in Japan, with almost all cases occurring among men who have sex with men, according to a poster presented at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this month in Denver. For those treated early with pegylated interferon plus ribavirin, the cure rate was high at 80%.
Hepatitis C Vaccine Is Safe and Induces Immune Responses in Early Human Trial
- Details
- Category: HCV Vaccines
- Published on Friday, 07 November 2014 00:00
- Written by University of Oxford
A new hepatitis C vaccine demonstrated good safely and tolerability in a first-in-humans Phase 1 clinical trial, with only mild and transient side effects, according to a report in the November 5 edition of Science Translational Medicine. The vaccine, which mimics immune responses in people who naturally clear hepatitis C virus (HCV) infection, led to increased production of T-cells targeting the virus. Phase 2 studies are now underway in Baltimore and San Francisco, with results expected in 2016.
Hepatitis C Epidemic Mostly Confined to HIV Positive Gay Men in London
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 21 August 2013 00:00
- Written by Liz Highleyman
HIV negative gay and bisexual men in London have a hepatitis C prevalence similar to that of the general population, confirming that outbreaks of sexually transmitted HCV among men who have sex with men are largely limited to those who are HIV positive, according to a report in the June 18, 2013, advance edition of HIV Medicine.
HCV Sexual Transmission: HIV Negative May Be at Risk, More Awareness and Testing Needed
- Details
- Category: HCV Sexual Transmission
- Published on Friday, 10 October 2014 00:00
- Written by Liz Highleyman
Hepatitis C virus (HCV) is known to be sexually transmitted among HIV positive men who have sex with men, but HIV negative men may be at risk as well, according to recent reports. Other recent studies have looked at awareness of HCV sexual transmission and screening practices, suggesting that improvement is needed in both areas.
IAS 2013: Hepatitis C Reinfection Occurs Frequently Among Gay Men Living with HIV in London
- Details
- Category: HCV Sexual Transmission
- Published on Wednesday, 03 July 2013 00:00
- Written by Michael Carter
There is a high incidence of hepatitis C virus (HCV) reinfection among gay men living with HIV in London, results of a study published in the online edition of AIDS show. The results were also presented at 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this week in Kuala Lumpur.
July 28 Is World Hepatitis Day [VIDEO]
- Details
- Category: HCV Treatment
- Published on Monday, 28 July 2014 00:00
- Written by HIVandHepatitis.com
July 28 is World Hepatitis Day, an opportunity to raise awareness about viral hepatitis and its consequences. This year's theme -- "Think Again" -- emphasizes that while hepatitis B and C are major causes of death worldwide, viral hepatitis remains remarkably neglected. The World Health Organization (WHO) and others held a press briefing at the 20th International AIDS Conference last week in Melbourne to raise awareness.
Antiretroviral PrEP Prevents HIV Transmission among Injection Drug Users
- Details
- Category: Injection Drug Use
- Published on Thursday, 13 June 2013 00:00
- Written by Liz Highleyman
Pre-exposure prophylaxis (PrEP) using daily oral tenofovir (Viread) reduced the risk of HIV acquisition among injection drug users in Thailand by half, according to findings from the Bangkok Tenofovir Study, published in the June 13, 2013, advance online edition of The Lancet. These findings led the CDC to recommend that PrEP be "considered as one of several prevention options for persons at very high risk for HIV acquisition" through injection drug use.
Web Design and Development by